Stem cell treatment for Lou Gehrig’s disease may be safe

A phase II clinical trial in people with amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, suggests that transplanting human stem cells into the spinal cord may be done safely. While the study was not designed to determine whether the treatment was effective, researchers noted that it did not slow down the progression of the disease.